Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Worm

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Genitourinary Medicine|April 1, 1997
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study GroupN J Bodsworth, R J Crooks, S Borelli, et al.
Ugeskrift for Laeger|March 31, 1986
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen]C S Petersen, G L Wantzin, J Gerstoft, et al.
International Journal of Cancer|January 14, 1998
Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidenceE I Svare, S K Kjaer, A M Worm, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk womenE I Svare, S K Kjaer, B Nonnenmacher, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Genitourinary Medicine|April 1, 1997
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study GroupN J Bodsworth, R J Crooks, S Borelli, et al.
Ugeskrift for Laeger|March 31, 1986
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen]C S Petersen, G L Wantzin, J Gerstoft, et al.
International Journal of Cancer|January 14, 1998
Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidenceE I Svare, S K Kjaer, A M Worm, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk womenE I Svare, S K Kjaer, B Nonnenmacher, et al.
Pageof 11